Patrick Amstutz
Gründer bei MOLECULAR PARTNERS AG
Vermögen: 3 Mio $ am 30.04.2024
Aktive Positionen von Patrick Amstutz
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MOLECULAR PARTNERS AG | Direktor/Vorstandsmitglied | 12.05.2017 | - |
| Vorstandsvorsitzender | 07.11.2016 | - | |
| Gründer | 23.11.2004 | - | |
| Geschäftsführer | 23.11.2004 | 12.05.2017 | |
| Corporate Officer/Principal | 23.11.2004 | 23.11.2004 | |
Swiss Biotech Association
 Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | Präsident | 03.05.2022 | - |
| Corporate Officer/Principal | 01.01.2017 | 03.05.2022 | |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | - | - |
Karriereverlauf von Patrick Amstutz
Ausbildung von Patrick Amstutz
| University of Zurich | Doctorate Degree |
| Swiss Federal Institute of Technology | Graduate Degree |
Statistik
International
| Schweiz | 4 |
| Deutschland | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MOLECULAR PARTNERS AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | Commercial Services |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Health Technology |
- Börse
- Insiders
- Patrick Amstutz
- Erfahrung
